Supreme Court Affordable Care Act Ruling Must Now Lead to Implementation That Will Promote Innovation and Expand Access

  • Contact: Stephanie Fischer
  • Phone: 202-312-9263
  • Email: sfischer@bio.org
  • Recommend
  • Tweet
  • Print
  • Email

 

Pleased to move forward on biosimilars pathway

Washington, D.C. (June 28, 2012) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement on the ruling issued today by the U.S. Supreme Court regarding the Affordable Care Act:

“BIO will continue to work with relevant federal and state agencies to ensure implementation of the law in a manner that helps enable the U.S. biotech community’s continued development of lifesaving cures and other medical breakthroughs while expanding patient access to these critical cures, medicines and innovations.  We will work to ensure that biotech researchers can continue to address the diseases of today while conducting the research and investment required to develop the advanced medicines and cures of tomorrow.

“We also will continue our work with U.S. Food and Drug Administration (FDA) to implement the bipartisan-backed biosimilars pathway that was enacted under the law.  Specifically, we will advocate for implementation approaches that ensure patient safety, expand patient access and competition, and provide necessary and fair incentives that will help spur continued biomedical breakthroughs.  FDA regulations and guidance must help today’s patients while enabling the biotech community to move into tomorrow  with cures and continued breakthroughs so  our children and grandchildren won't have to live with the same diseases we have faced and, perhaps, one day, any diseases at all.

“In addition, BIO will continue to support efforts to repeal the Independent Payment Advisory Board (IPAB), which threatens patient access to needed cures and medical breakthroughs.”

Upcoming BIO Events 

BIO India International Conference
September 12 – 13, 2012
Mumbai, India

Livestock Biotech Summit
September 19 – 21, 2012
Kansas City, MO

BIO Investor Forum
October 9-10, 2012
San Francisco, CA

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
October 10 – 12, 2012
Vancouver, Canada

The BIO Convention in China
October 24 – 25, 2012
Shanghai, China

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.